A DirEct to PatieNt Study in Chronic Pain

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY

To compile real-world, direct from patient clinical outcomes and objective metrics in patients who have received or plan to receive a commercially approved interventional medical device therapy/procedure for chronic pain in routine clinical practice.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 22
Healthy Volunteers: f
View:

• Patient is planning to receive or has received a commercially approved interventional medical device therapy/procedure to treat chronic pain, ascertained from self-reporting

• Age ≥ 22 years at time of eligibility screening, ascertained by self-reported age at time of eligibility screening

• Proficient in written and spoken English, defined by self-reporting of comfort reading, writing and speaking English

Locations
United States
California
Boston Scientific Neuromodulation
RECRUITING
Valencia
Contact Information
Primary
Alison Lewis
BSNClinicalTrials@bsci.com
855-213-9890
Backup
Diane Keesey
BSNClinicalTrials@bsci.com
855-213-9890
Time Frame
Start Date: 2023-01-10
Estimated Completion Date: 2029-12
Participants
Target number of participants: 50000
Treatments
Medical Device Therapy/Procedure for Chronic Pain
Related Therapeutic Areas
Sponsors
Leads: Boston Scientific Corporation

This content was sourced from clinicaltrials.gov